HB5233 EngrossedLRB097 20167 RPM 65645 b

1    AN ACT concerning public health.
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4    Section 5. The Illinois Food, Drug and Cosmetic Act is
5amended by changing Sections 2.4, 3.22, 5, and 6 as follows:
6    (410 ILCS 620/2.4)  (from Ch. 56 1/2, par. 502.4)
7    Sec. 2.4. (a) "Drug" means (1) articles recognized in the
8official United States Pharmacopoeia - National Formulary,
9official Homeopathic Pharmacopoeia of the United States,
10United States Dispensatory, or Remington's Practice of
11Pharmacy, or any supplement to any of them; and (2) articles
12intended for use in the diagnosis, cure, mitigation, treatment
13or prevention of disease in man or other animals; and (3)
14articles (other than food) intended to affect the structure or
15any function of the body of man or other animals; and (4)
16articles intended for use as a component of any article
17specified in clause (1), (2) or (3); but does not include
18devices or their components, parts or accessories.
19    (b) "Synthetic drug product" means any product that
20contains a substance defined as a controlled substance under
21subsections (d) and (e) of Section 204 of the Illinois
22Controlled Substances Act. Products approved by the U.S. Food
23and Drug Administration for human consumption are not synthetic



HB5233 Engrossed- 2 -LRB097 20167 RPM 65645 b

1drug products.
2(Source: P.A. 84-891.)
3    (410 ILCS 620/3.22)  (from Ch. 56 1/2, par. 503.22)
4    Sec. 3.22. (a) Whoever knowingly distributes, or possesses
5with intent to distribute, human growth hormone for any use in
6humans other than the treatment of a disease or other
7recognized medical condition, where the use has been authorized
8by the Secretary of Health and Human Services and under the
9order of a physician, is guilty of a Class 3 felony, and may be
10fined an amount not to exceed $50,000. As used in this Section,
11the term "human growth hormone" means somatrem, somatropin, or
12an analogue of either of them.
13    (b) Whoever distributes, or possesses with intent to
14distribute, a synthetic drug product or a drug that is
15misbranded under this Act is guilty of a Class 2 felony and may
16be fined an amount not to exceed $100,000. A person convicted
17of a second or subsequent violation of this Section is guilty
18of a Class 1 felony, the fine for which shall not exceed
20    (c) Whoever falsely advertises a synthetic drug product or
21a drug that is misbranded is guilty of a Class 3 felony and may
22be fined an amount not to exceed $100,000.
23    (d) Whoever commits any offense set forth in this Section
24and the offense involves an individual under 18 years of age is
25punishable by not more than 10 years imprisonment, and twice



HB5233 Engrossed- 3 -LRB097 20167 RPM 65645 b

1the fine authorized above. Any conviction for a violation of
2this Section shall be considered a violation of the Illinois
3Controlled Substances Act for the purposes of forfeiture under
4Section 505 of such Act. As used in this Section the term
5"human growth hormone" means somatrem, somatropin, or an
6analogue of either of them. The Department of State Police and
7Department of Professional Regulation are authorized to
8investigate offenses punishable by this Section.
9    (e) Any person convicted under this Section is subject to
10the forfeiture provisions set forth in subsections (c), (d),
11(e), (f), (g), (h), and (i) of Section 3.23 of this Act.
12(Source: P.A. 87-754.)
13    (410 ILCS 620/5)  (from Ch. 56 1/2, par. 505)
14    Sec. 5. (a) A person who violates any of the provisions of
15this Act, other than Sections 3.22 and 6, is guilty of a Class
16C misdemeanor; but if the violation is committed after a
17conviction of such person under this Section has become final,
18the person shall be guilty of a Class A misdemeanor. A person
19who violates the provisions of Section 6 of this Act is guilty
20of a Class 3 felony A misdemeanor; but if the violation is
21committed after a conviction of such person under this Section
22has become final, the person shall be guilty of a Class 2 4
24    (b) No person is subject to the penalties of subsection (a)
25of this Section for (1) violating Section 3.1 or 3.3 if he



HB5233 Engrossed- 4 -LRB097 20167 RPM 65645 b

1establishes a guaranty or undertaking signed by and containing
2the name and address of the person residing in the State of
3Illinois from whom he received the article in good faith, to
4the effect that the article is not adulterated or misbranded
5within the meaning of this Act, designating this Act; or (2)
6for having violated clause (2) of Section 3.16 if such person
7acted in good faith and had no reason to believe that the use
8of the punch, die, plate, stone or other thing involved would
9result in a drug being a counterfeit drug, or for having
10violated clause (3) of Section 3.16 if the person doing the act
11or causing it to be done acted in good faith and had no reason
12to believe that the drug was a counterfeit drug.
13    (c) No publisher, radio-broadcast licensee, agency or
14medium for the dissemination of an advertisement, except the
15manufacturer, packer, distributor or seller of the article to
16which a false advertisement relates is liable under this
17Section for the dissemination of such false advertisement
18unless he has refused on the request of the Director to furnish
19the Director the name and post office address of the
20manufacturer, packer, distributor, seller or advertising
21agency residing in the State of Illinois who causes him to
22disseminate such advertisement.
23    (d) No person shall be subject to the penalties of
24subsection (a) of this Section for a violation of Section 3
25involving misbranded food if the violation exists solely
26because the food is misbranded under subsection (c) of Section



HB5233 Engrossed- 5 -LRB097 20167 RPM 65645 b

111 because of its advertising, and no person shall be subject
2to the penalties of subsection (a) of this Section for such a
3violation unless the violation is committed with the intent to
4defraud or mislead.
5(Source: P.A. 86-704; 87-754.)
6    (410 ILCS 620/6)  (from Ch. 56 1/2, par. 506)
7    Sec. 6. (a) When an authorized agent of the Director finds
8or has probable cause to believe that any food, drug, device or
9cosmetic is adulterated or so misbranded as to be dangerous or
10fraudulent within the meaning of this Act, or is in violation
11of Section 12, 17 or 17.1 of this Act, or is suspected to be a
12synthetic drug product, he or she shall affix to such article a
13tag or other appropriate marking giving notice that the article
14is or is suspected of being adulterated or misbranded and has
15been detained or embargoed and warning all persons not to
16remove or dispose of such article by sale or otherwise until
17permission for removal or disposal is given by such agent or
18the court. It is unlawful for any person to remove or dispose
19of such detained or embargoed article by sale or otherwise
20without such permission.
21    (b) When an article detained or embargoed under subsection
22(a) of this Section is found by such agent to be adulterated or
23misbranded or to be in violation of Section 12, 17 or 17.1 of
24this Act or is suspected to be a synthetic drug product, he or
25she shall petition the circuit court in whose jurisdiction the



HB5233 Engrossed- 6 -LRB097 20167 RPM 65645 b

1article is detained or embargoed for a libel for condemnation
2of such article. When such agent finds that an article so
3detained or embargoed is not adulterated or misbranded or is
4not a synthetic drug product, he or she shall remove the tag or
5other marking.
6    (c) If the court finds that a detained or embargoed article
7is adulterated or misbranded, such article shall, after entry
8of the judgment, be destroyed at the expense of the claimant
9thereof, under the supervision of such agent, and all court
10costs and fees, and storage and other proper expenses, shall be
11taxed against the claimant of such article or his or her agent.
12However, when the adulteration or misbranding can be corrected
13by proper labeling or processing of the article, the court,
14after entry of the judgment and after such costs, fees and
15expenses have been paid and a good and sufficient bond,
16conditioned that such article shall be so labeled or processed,
17has been executed, may by order direct that such article be
18delivered to the claimant thereof for such labeling or
19processing under the supervision of an agent of the Director.
20The expense of such supervision shall be paid by the claimant.
21The article shall be returned to the claimant and the bond
22shall be discharged on the representation to the court by the
23Director that the article is no longer in violation of this
24Act, and that the expenses of such supervision have been paid.
25    (d) Whenever the Director or any of his or her authorized
26agents finds in any room, building, vehicle of transportation



HB5233 Engrossed- 7 -LRB097 20167 RPM 65645 b

1or other structure, any meat, sea food, poultry, vegetable,
2fruit or other perishable articles which contain any filthy,
3decomposed or putrid substance, or that may be poisonous or
4deleterious to health or otherwise unsafe, the same being
5hereby declared to be a nuisance, the Director or his or her
6authorized agent shall condemn or destroy the same, or in any
7other manner render the same unusable as human food.
8(Source: P.A. 85-564.)
9    Section 10. The Illinois Controlled Substances Act is
10amended by changing Section 204 as follows:
11    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
12    Sec. 204. (a) The controlled substances listed in this
13Section are included in Schedule I.
14    (b) Unless specifically excepted or unless listed in
15another schedule, any of the following opiates, including their
16isomers, esters, ethers, salts, and salts of isomers, esters,
17and ethers, whenever the existence of such isomers, esters,
18ethers and salts is possible within the specific chemical
20        (1) Acetylmethadol;
21        (1.1) Acetyl-alpha-methylfentanyl
22    (N-[1-(1-methyl-2-phenethyl)-
23    4-piperidinyl]-N-phenylacetamide);
24        (2) Allylprodine;



HB5233 Engrossed- 8 -LRB097 20167 RPM 65645 b

1        (3) Alphacetylmethadol, except
2    levo-alphacetylmethadol (also known as levo-alpha-
3    acetylmethadol, levomethadyl acetate, or LAAM);
4        (4) Alphameprodine;
5        (5) Alphamethadol;
6        (6) Alpha-methylfentanyl
7    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
8    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
9    propanilido) piperidine;
10        (6.1) Alpha-methylthiofentanyl
11    (N-[1-methyl-2-(2-thienyl)ethyl-
12    4-piperidinyl]-N-phenylpropanamide);
13        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
14        (7.1) PEPAP
15    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
16        (8) Benzethidine;
17        (9) Betacetylmethadol;
18        (9.1) Beta-hydroxyfentanyl
19    (N-[1-(2-hydroxy-2-phenethyl)-
20    4-piperidinyl]-N-phenylpropanamide);
21        (10) Betameprodine;
22        (11) Betamethadol;
23        (12) Betaprodine;
24        (13) Clonitazene;
25        (14) Dextromoramide;
26        (15) Diampromide;



HB5233 Engrossed- 9 -LRB097 20167 RPM 65645 b

1        (16) Diethylthiambutene;
2        (17) Difenoxin;
3        (18) Dimenoxadol;
4        (19) Dimepheptanol;
5        (20) Dimethylthiambutene;
6        (21) Dioxaphetylbutyrate;
7        (22) Dipipanone;
8        (23) Ethylmethylthiambutene;
9        (24) Etonitazene;
10        (25) Etoxeridine;
11        (26) Furethidine;
12        (27) Hydroxpethidine;
13        (28) Ketobemidone;
14        (29) Levomoramide;
15        (30) Levophenacylmorphan;
16        (31) 3-Methylfentanyl
17    (N-[3-methyl-1-(2-phenylethyl)-
18    4-piperidyl]-N-phenylpropanamide);
19        (31.1) 3-Methylthiofentanyl
20    (N-[(3-methyl-1-(2-thienyl)ethyl-
21    4-piperidinyl]-N-phenylpropanamide);
22        (32) Morpheridine;
23        (33) Noracymethadol;
24        (34) Norlevorphanol;
25        (35) Normethadone;
26        (36) Norpipanone;



HB5233 Engrossed- 10 -LRB097 20167 RPM 65645 b

1        (36.1) Para-fluorofentanyl
2    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
3    4-piperidinyl]propanamide);
4        (37) Phenadoxone;
5        (38) Phenampromide;
6        (39) Phenomorphan;
7        (40) Phenoperidine;
8        (41) Piritramide;
9        (42) Proheptazine;
10        (43) Properidine;
11        (44) Propiram;
12        (45) Racemoramide;
13        (45.1) Thiofentanyl
14    (N-phenyl-N-[1-(2-thienyl)ethyl-
15    4-piperidinyl]-propanamide);
16        (46) Tilidine;
17        (47) Trimeperidine;
18        (48) Beta-hydroxy-3-methylfentanyl (other name:
19    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
20    N-phenylpropanamide).
21    (c) Unless specifically excepted or unless listed in
22another schedule, any of the following opium derivatives, its
23salts, isomers and salts of isomers, whenever the existence of
24such salts, isomers and salts of isomers is possible within the
25specific chemical designation:
26        (1) Acetorphine;



HB5233 Engrossed- 11 -LRB097 20167 RPM 65645 b

1        (2) Acetyldihydrocodeine;
2        (3) Benzylmorphine;
3        (4) Codeine methylbromide;
4        (5) Codeine-N-Oxide;
5        (6) Cyprenorphine;
6        (7) Desomorphine;
7        (8) Diacetyldihydromorphine (Dihydroheroin);
8        (9) Dihydromorphine;
9        (10) Drotebanol;
10        (11) Etorphine (except hydrochloride salt);
11        (12) Heroin;
12        (13) Hydromorphinol;
13        (14) Methyldesorphine;
14        (15) Methyldihydromorphine;
15        (16) Morphine methylbromide;
16        (17) Morphine methylsulfonate;
17        (18) Morphine-N-Oxide;
18        (19) Myrophine;
19        (20) Nicocodeine;
20        (21) Nicomorphine;
21        (22) Normorphine;
22        (23) Pholcodine;
23        (24) Thebacon.
24    (d) Unless specifically excepted or unless listed in
25another schedule, any material, compound, mixture, or
26preparation which contains any quantity of the following



HB5233 Engrossed- 12 -LRB097 20167 RPM 65645 b

1hallucinogenic substances, or which contains any of its salts,
2isomers and salts of isomers, whenever the existence of such
3salts, isomers, and salts of isomers is possible within the
4specific chemical designation (for the purposes of this
5paragraph only, the term "isomer" includes the optical,
6position and geometric isomers):
7        (1) 3,4-methylenedioxyamphetamine
8    (alpha-methyl,3,4-methylenedioxyphenethylamine,
9    methylenedioxyamphetamine, MDA);
10        (1.1) Alpha-ethyltryptamine
11    (some trade or other names: etryptamine;
12    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
13    3-(2-aminobutyl)indole; a-ET; and AET);
14        (2) 3,4-methylenedioxymethamphetamine (MDMA);
15        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
16    (also known as: N-ethyl-alpha-methyl-
17    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
18    and MDEA);
19        (2.2) N-Benzylpiperazine (BZP);
20        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
21        (4) 3,4,5-trimethoxyamphetamine (TMA);
22        (5) (Blank);
23        (6) Diethyltryptamine (DET);
24        (7) Dimethyltryptamine (DMT);
25        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
26        (9) Ibogaine  (some trade and other names:



HB5233 Engrossed- 13 -LRB097 20167 RPM 65645 b

1    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
2    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
3    indole; Tabernanthe iboga);
4        (10) Lysergic acid diethylamide;
5        (10.1) Salvinorin A;
6        (10.5) Salvia divinorum (meaning all parts of the plant
7    presently classified botanically as Salvia divinorum,
8    whether growing or not, the seeds thereof, any extract from
9    any part of that plant, and every compound, manufacture,
10    salts, isomers, and salts of isomers whenever the existence
11    of such salts, isomers, and salts of isomers is possible
12    within the specific chemical designation, derivative,
13    mixture, or preparation of that plant, its seeds or
14    extracts);
15        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
16        (12) Peyote (meaning all parts of the plant presently
17    classified botanically as Lophophora williamsii Lemaire,
18    whether growing or not, the seeds thereof, any extract from
19    any part of that plant, and every compound, manufacture,
20    salts, derivative, mixture, or preparation of that plant,
21    its seeds or extracts);
22        (13) N-ethyl-3-piperidyl benzilate (JB 318);
23        (14) N-methyl-3-piperidyl benzilate;
24        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
25    (also known as N-hydroxy-alpha-methyl-
26    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);



HB5233 Engrossed- 14 -LRB097 20167 RPM 65645 b

1        (15) Parahexyl; some trade or other names:
2    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
3    dibenzo (b,d) pyran; Synhexyl;
4        (16) Psilocybin;
5        (17) Psilocyn;
6        (18) Alpha-methyltryptamine (AMT);
7        (19) 2,5-dimethoxyamphetamine
8    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
9        (20) 4-bromo-2,5-dimethoxyamphetamine
10    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
11    4-bromo-2,5-DMA);
12        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
13    Some trade or other names: 2-(4-bromo-
14    2,5-dimethoxyphenyl)-1-aminoethane;
15    alpha-desmethyl DOB, 2CB, Nexus;
16        (21) 4-methoxyamphetamine
17    (4-methoxy-alpha-methylphenethylamine;
18    paramethoxyamphetamine; PMA);
19        (22) (Blank);
20        (23) Ethylamine analog of phencyclidine.
21    Some trade or other names:
22    N-ethyl-1-phenylcyclohexylamine,
23    (1-phenylcyclohexyl) ethylamine,
24    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
25        (24) Pyrrolidine analog of phencyclidine. Some trade
26    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,



HB5233 Engrossed- 15 -LRB097 20167 RPM 65645 b

1    PHP;
2        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
3        (26) 2,5-dimethoxy-4-ethylamphetamine
4    (another name: DOET);
5        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
6    (another name: TCPy);
7        (28) (Blank);
8        (29) Thiophene analog of phencyclidine (some trade
9    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
10    2-thienyl analog of phencyclidine; TPCP; TCP);
11        (30) Bufotenine (some trade or other names:
12    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
13    3-(2-dimethylaminoethyl)-5-indolol;
14    5-hydroxy-N,N-dimethyltryptamine;
15    N,N-dimethylserotonin; mappine);
16        (31)  1-Pentyl-3-(1-naphthoyl)indole 
17    Some trade or other names: JWH-018; 
18        (32) 1-Butyl-3-(1-naphthoyl)indole 
19    Some trade or other names: JWH-073;  
20        (33) 1-[(5-fluoropentyl)-1H-indol-3-yl]- 
21    (2-iodophenyl)methanone 
22    Some trade or other names: AM-694;
23        (34) 2-[(1R,3S)-3-hydroxycyclohexyl]-5-
24    (2-methyloctan-2-yl)phenol 
25    Some trade or other names: CP 47,497 47, 497
26    and its C6, C8 and C9 homologs;



HB5233 Engrossed- 16 -LRB097 20167 RPM 65645 b

1        (34.5) (33) 2-[(1R,3S)-3-hydroxycyclohexyl]-5- 
2    (2-methyloctan-2-yl)phenol), where side chain n=5;  
3    and homologues where side chain n=4, 6, or 7;  Some  
4    trade or other names: CP 47,497; 
5        (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
6    (2-methyloctan-2-yl)-6a,7, 
7    10,10a-tetrahydrobenzo[c]chromen-1-ol
8    Some trade or other names: HU-210; 
9        (35.5) (34) (6aS,10aS)-9-(hydroxymethyl)-6,6- 
10    dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 
11    tetrahydrobenzo[c]chromen-1-ol, its isomers,  
12    salts, and salts of isomers; Some trade or other  
13    names: HU-210, Dexanabinol; 
14        (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
15    6,6-dimethyl-3-(2-methyloctan-2-yl)- 
16    6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
17    Some trade or other names: HU-211;
18        (37) (2-methyl-1-propyl-1H-indol-
19    3-yl)-1-naphthalenyl-methanone 
20    Some trade or other names: JWH-015;
21        (38) 4-methoxynaphthalen-1-yl-
22    (1-pentylindol-3-yl)methanone 
23    Some trade or other names: JWH-081;
24        (39) (1-Pentyl-3-(4-methyl-1-naphthoyl)indole
25    Some trade or other names: JWH-122;
26        (40) 2-(2-methylphenyl)-1-(1-pentyl-



HB5233 Engrossed- 17 -LRB097 20167 RPM 65645 b

1    1H-indol-3-yl)-ethanone 
2    Some trade or other names: JWH-251;
3        (41) 1-(2-cyclohexylethyl)-3- 
4    (2-methoxyphenylacetyl)indole 
5    Some trade or other names: RCS-8, BTW-8 and SR-18; . 
6        (42) (33) Any compound structurally derived from 
7    3-(1-naphthoyl)indole or 1H-indol-3-yl- 
8    (1-naphthyl)methane by substitution at the 
9    nitrogen atom of the indole ring by alkyl, haloalkyl, 
10    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
11    2-(4-morpholinyl)ethyl whether or not further 
12    substituted in the indole ring to any extent, whether 
13    or not substituted in the naphthyl ring to any extent; 
14        (43) (34) Any compound structurally derived from 
15    3-(1-naphthoyl)pyrrole by substitution at the nitrogen 
16    atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, 
17    cycloalkylmethyl, cycloalkylethyl or 
18    2-(4-morpholinyl)ethyl, whether or not further 
19    substituted in the pyrrole ring to any extent, whether 
20    or not substituted in the naphthyl ring to any extent; 
21        (44) (35) Any compound structurally derived from 
22    1-(1-naphthylmethyl)indene by substitution 
23    at the 3-position of the indene ring by alkyl, haloalkyl, 
24    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
25    2-(4-morpholinyl)ethyl whether or not further 
26    substituted in the indene ring to any extent, whether 



HB5233 Engrossed- 18 -LRB097 20167 RPM 65645 b

1    or not substituted in the naphthyl ring to any extent; 
2        (45) (36) Any compound structurally derived from 
3    3-phenylacetylindole by substitution at the 
4    nitrogen atom of the indole ring with alkyl, haloalkyl, 
5    alkenyl, cycloalkylmethyl, cycloalkylethyl or 
6    2-(4-morpholinyl)ethyl, whether or not further 
7    substituted in the indole ring to any extent, whether 
8    or not substituted in the phenyl ring to any extent; 
9        (46) (37) Any compound structurally derived from 
10    2-(3-hydroxycyclohexyl)phenol by substitution 
11    at the 5-position of the phenolic ring by alkyl, 
12    haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl 
13    or 2-(4-morpholinyl)ethyl, whether or not substituted 
14    in the cyclohexyl ring to any extent; . 
15        (47) (33) 3,4-Methylenedioxymethcathinone 
16    Some trade or other names: Methylone; 
17        (48) (34) 3,4-Methyenedioxypyrovalerone 
18    Some trade or other names: MDPV; 
19        (49) (35) 4-Methylmethcathinone 
20    Some trade or other names: Mephedrone; 
21        (50) (36) 4-methoxymethcathinone; 
22        (51) (37) 4-Fluoromethcathinone; 
23        (52) (38) 3-Fluoromethcathinone; . 
24        (53) (35) 2,5-Dimethoxy-4-(n)-propylthio- 
25    phenethylamine; 
26        (54) (36) 5-Methoxy-N,N-diisopropyltryptamine; . 



HB5233 Engrossed- 19 -LRB097 20167 RPM 65645 b

1        (55) Pentedrone. 
2    (e) Unless specifically excepted or unless listed in
3another schedule, any material, compound, mixture, or
4preparation which contains any quantity of the following
5substances having a depressant effect on the central nervous
6system, including its salts, isomers, and salts of isomers
7whenever the existence of such salts, isomers, and salts of
8isomers is possible within the specific chemical designation:
9        (1) mecloqualone;
10        (2) methaqualone; and
11        (3) gamma hydroxybutyric acid.
12    (f) Unless specifically excepted or unless listed in
13another schedule, any material, compound, mixture, or
14preparation which contains any quantity of the following
15substances having a stimulant effect on the central nervous
16system, including its salts, isomers, and salts of isomers:
17        (1) Fenethylline;
18        (2) N-ethylamphetamine;
19        (3) Aminorex (some other names:
20    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
21    4-5-dihydro-5-phenyl-2-oxazolamine) and its
22    salts, optical isomers, and salts of optical isomers;
23        (4) Methcathinone (some other names:
24    2-methylamino-1-phenylpropan-1-one;
25    Ephedrone; 2-(methylamino)-propiophenone;
26    alpha-(methylamino)propiophenone; N-methylcathinone;



HB5233 Engrossed- 20 -LRB097 20167 RPM 65645 b

1    methycathinone; Monomethylpropion; UR 1431) and its
2    salts, optical isomers, and salts of optical isomers;
3        (5) Cathinone (some trade or other names:
4    2-aminopropiophenone; alpha-aminopropiophenone;
5    2-amino-1-phenyl-propanone; norephedrone);
6        (6) N,N-dimethylamphetamine (also known as:
7    N,N-alpha-trimethyl-benzeneethanamine;
8    N,N-alpha-trimethylphenethylamine);
9        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
10    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
11        (8) 3,4-Methylenedioxypyrovalerone (MDPV).
12    (g) Temporary listing of substances subject to emergency
13scheduling. Any material, compound, mixture, or preparation
14that contains any quantity of the following substances:
15        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
16    (benzylfentanyl), its optical isomers, isomers, salts,
17    and salts of isomers;
18        (2) N-[1(2-thienyl)
19   methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
20   its optical isomers, salts, and salts of isomers.
21(Source: P.A. 96-347, eff. 1-1-10; 96-1285, eff. 1-1-11;
2297-192, eff. 7-22-11; 97-193, eff. 1-1-12; 97-194, eff.
237-22-11; 97-334, eff. 1-1-12; revised 9-14-11.)